Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 1312
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT00976248 | Everolimus (RAD001) in Primary Therapy of Waldenstrom's Macroglobulinemia | ||
| NCT01058408 | RAD001 With Weekly Cisplatin and Radiation Therapy in Patients With Locally Advanced Head and Neck Cancer | ||
| NCT00928018 | Tacrolimus/Sirolimus/Methotrexate vs Tacrolimus/Methotrexate or Cyclosporine/Mycophenolate Mofetil for GVHD Prophylaxis After Reduced Intensity Allogeneic Stem Cell Transplantation for Patients With Lymphoma | ||
| NCT07662239 | Bridging Adolescent and Young Adult Sarcoma Survivors With Personalized Oncology Exercise Service (AYA-ONE): A Pilot Intervention | ||
| NCT00788775 | Nilotinib in TKI Resistant or Intolerant Patients With Metastatic Mucosal, Acral, or Chronically Sun Damaged Melanoma | ||
| NCT00585637 | Vitamin D for Chemoprevention | ||
| NCT02086175 | A Phase 2 Clinical Trial of Rituxan and B-Glucan PGG in Relapsed Indolent Non-Hodgkin Lymphoma | ||
| NCT05600101 | Development and Piloting an Avatar-based Intervention to Support Patients Undergoing Stem Cell Transplantation | ||
| NCT06795139 | Pilot of a Trial Enrollment Diversity Dashboard | ||
| NCT03657628 | Physical Activity, Proliferation and Immune Markers in Benign Breast Tissue | ||
| NCT03747419 | Avelumab and Radiation in Muscle-Invasive Bladder Cancer | ||
| NCT01339039 | Plerixafor (AMD3100) and Bevacizumab for Recurrent High-Grade Glioma | ||
| NCT03277469 | Optimizing Brachytherapy Application and Delivery With MRI Guidance for Gynecologic Cancer | ||
| NCT03304756 | Study of Neoadjuvant Treatment of Locally Advanced Breast Cancer With CAP Regimen | ||
| NCT03316586 | A Phase II Study of Nivolumab in Combination With Cabozantinib for Metastatic Triple-negative Breast Cancer | ||
| NCT07130786 | Prophylactic Anti-Seizure Medication vs No Anti-Seizure Medication for Patients With Primary Motor Cortex Brain Metastases | ||
| NCT02956473 | Supine MRI in Breast Cancer Patients Undergoing Upfront Surgery or Receiving Neoadjuvant Therapy | ||
| NCT03846583 | Tucatinib + Abemaciclib + Herceptin for HER2+ MBC | ||
| NCT05176288 | Avelumab, Palbociclib and Axitinib in Advanced RCC | ||
| NCT02784366 | GI Complications in Cancer Immunotherapy Patients | ||
| NCT00165451 | A Trial of Thalidomide, Celecoxib, Etoposide and Cyclophosphamide in Patients With Relapsed or Progressive Cancer | ||
| NCT05546411 | A Trial of NIS793 With FOLFIRINOX in Pancreatic Cancer | ||
| NCT00574899 | Prostate Biomarker Study | ||
| NCT06650514 | A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma | ||
| NCT00207636 | Community Interventions in Non-medical Settings to Increase Informed Decision Making for Prostate Cancer Screening | ||
| NCT06803875 | Study of hALK.CAR T Cells for Patients With Relapsed/Refractory High-risk Neuroblastoma | ||
| NCT02648997 | An Open-Label Phase II Study of Nivolumab or Nivolumab/Ipilimumab in Adult Participants With Progessive/ Recurrent Meningioma | ||
| NCT01664091 | Cosmetic Result/Toxicity in Post-Mastectomy Immediate Reconstruction Expander+RT | ||
| NCT02041325 | Investigation of the Enhancement of Response to Hepatitis B Vaccine by Lenalidomide in Plasma Cell Dyscrasias | ||
| NCT05934448 | Pembro Plus CAR T-cell Therapy in R/R in PMBCL | ||
| NCT00694577 | Partial Breast Irradiation (PBI) for Selected Patients With Early Invasive or Non-Invasive Breast Cancer | ||
| NCT03137537 | Ivabradine in the Management of Cardiac Autonomic Dysfunction Associated With Thoracic Radiation Therapy. | ||
| NCT02912572 | Avelumab in Patients With MSS, MSI-H and POLE-mutated Recurrent or Persistent Endometrial Cancer and of Avelumab/Talazoparib and Avelumab/Axitinib in Patients With MSS Recurrent or Persistent Endometrial Cancer | ||
| NCT01065467 | Panobinostat (LBH589) in Patients With Metastatic Melanoma | ||
| NCT05535192 | TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients | ||
| NCT00148707 | Study of Xyotax (CT-2103) in Patients With Metastatic Breast Cancer | ||
| NCT00003744 | Gemcitabine in Treating Patients With Advanced Salivary Gland Cancer That Cannot Be Removed During Surgery | ||
| NCT01827787 | Eribulin in HER2 Negative Metastatic BrCa | ||
| NCT02853500 | Effect of Surefire Infusion Device on Tumor Response to Regional Intra-arterial Therapy for Primary Liver Malignancies | ||
| NCT04674267 | Resilience and Equity in Aging, Cancer, and Health (REACH) | ||
| NCT06923397 | Interrupting Sedentary Time to Improve Cardiometabolic Health and Toxicity in Patients With Lymphoma Receiving Chemotherapy: The iSTAND Trial | ||
| NCT00601120 | RF Ablation of Treatment of Metastatic Lesions in Patients Undergoing Antiangiogenic Therapy for Stage IV Renal Cell Carcinoma | ||
| NCT02658396 | GO-203-2C + Bortezomib For Relapsed Or Refractory MM | ||
| NCT02375776 | Improving Outcomes in Cancer Patients on Oral Anti-Cancer Medications Using a Multi-modal Mobile Health Intervention | ||
| NCT05210101 | A Safety and Tolerability Study of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 in Immunocompromised Individuals | ||
| NCT00622401 | Vaccination of Patients With Breast Cancer With Dendritic Cell/Tumor Fusions and IL-12 | ||
| NCT01754025 | INHERIT EGFR - Studying Germline EGFR Mutations | ||
| NCT00148655 | Educational Interventions for Patients With DCIS | ||
| NCT00084838 | Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT | ||
| NCT02282722 | Improving Informed Consent for Palliative Chemotherapy |
